Telesair
Moving Patients from Hospitals to Home with Breakthrough Respiratory Solutions

The past two years of the pandemic resulted in a high level of oxygen emergencies, affecting millions of people across the world. Access to affordable and effective respiratory care solutions became arduous, where the demand for such medical devices greatly outweighed the supply. Addressing these pressing respiratory impediments, innovating new devices, and delivering the necessary treatments expeditiously is the need of the hour. While many organizations have been catering to the industry’s requirements, one startup, Telesair, presents the market with promising, viable, and cost-effective respiratory care solutions.

Founded in 2020, Telesair is driving advances in pneumatics and materials science linked with cutting-edge sensor technology to rejuvenate respiratory care. The company aims to resolve the issues of oxygen generation, conditioning, and delivery by utilizing real clinical data, engineering design, and IoT technology.

“With our respiratory care solutions, the goal is to move patients from hospitals to their homes as soon as possible,” says Bryan Liu, Founder and CEO of Telesair.

Telesair develops new generation respiratory devices intending to offer safer and more efficient breathing care equipment for clinical and home care. It disseminates its services to reduce the workload on therapists and nurses by automating respiratory care that includes new sensing technologies, two-dimension closed-loop automation, and artificial intelligence.

Those innovative technologies will contribute to moving patients out of hospital rooms faster, avoiding unnecessary, extended length of stay. With such endeavors, the company hopes to drive massive economic benefits for patients and the healthcare system.

Telesair strategizes to better regulate oxygen delivery processes in hospitals with its team of management with proven track record, industrial leading engineering talents, and key opinion leaders in clinical fields. They strive to address the lack of portable devices that support elevated oxygen levels outside healthcare institutions. The teams, via the company’s patented, soon-to-be launched respiratory care device, intend to provide long term care solutions for hospitals, rural health providers, long term care facilities, and home environments, raising the existing standard of healthcare and improving health outcomes. Telesair empowers patients to be fully equipped with remote control capabilities, making room for efficient oxygen flow management.

With our respiratory care solutions, the goal is to move patients from hospitals to their homes as soon as possible

In a short span of time, the company has filed for over ten patents for its products, received three patents so far, and expects to at least two more issued patents by the end of 2022. It has drawn the attention of various firms across the vertical and collaborated with an international medical device enterprise, where Telesair’s technology was licensed to be integrated into their products.

With such intuitively designed respiratory care solutions, Telesair hopes to increase a patient’s accessibility to affordable, safe, and remote oxygen therapy. The company is also determined to fill the gaps between supply and demand of existing respiratory care products as well. The mission for the company is to return the basic right of life back to people: breathing.